Navigation Links
Capstone Global Markets Hosts Charity Day to Help 4-Year Old Boy and Others Battling Batten Disease
Date:9/22/2009

NEW YORK, Sept. 22 /PRNewswire/ -- On October 1(st), The First Annual Capstone Global Markets Charity Day will support research focused on finding a cure to Batten Disease, a rare but fatal neurodegenerative disorder affecting children. The boutique derivatives broker dealer has committed to donating 100% of its net commissions that day to The Jasper Against Batten Fund. The newly created annual event is part of Capstone's commitment to giving back to the global community regardless of the macro financial environment. Every year, Capstone Global Markets will select specific charities to donate to, each with the common goal of helping children.

Jasper Duinstra is a 4-year old boy who was diagnosed with Batten Disease in March 2009, and has subsequently been experiencing seizures, deteriorating vision, limited vocabulary and paralysis in his legs. After the urgency of finding a cure for Batten Disease was brought to the attention of representatives of The New Jersey Nets, the basketball team committed to joining Capstone Global Markets on October 1(st) to raise money for the cause. The New Jersey Nets' involvement at the fundraiser will be highlighted by the participation of Nets president Rod Thorn, general manager (and former New York Knicks player) Kiki Vandeweghe, the Nets dance team and the Nets mascot. Each will be involved in thanking clients for their business and discussing the importance of the cause.

"We created this event to bring public awareness of this devastating disease and the urgency of Jasper's need for support," said Paul Britton, CEO of Capstone Holdings Group, LLC. "We are pleased with the enthusiasm from our clients to join us in this mission to help Jasper and other children affected by Batten Disease. Capstone Global Markets is committed to helping charities dedicated to helping children."

Batten Disease is a rare, fatal autosomal recessive inherited disease of the nervous system that begins in childhood. Symptoms of the disorder usually appear around ages 4-10, with the onset of a series of degenerative symptoms including seizures, vision impairment, deteriorating mental acuity and declining motor skills. Today, Batten Disease is always fatal. However, researchers are engaged. Scientists at Cornell University in New York are working on a gene therapy that offers hope, but funding is acute.

Jasper Against Batten Fund has teamed up with Partnership for Cures, a charitable non-profit 501(c)(3) foundation. All donations are tax deductible. For more information, please visit www.jasperagainstbatten.org.

"There is significant momentum already toward finding a cure for Batten Disease," concluded Mr. Britton. "Our hope is that Capstone Global Markets' donation will help fund the research that will enable so many families to find a better tomorrow with their kids."

About Capstone Global Markets, LLC

Capstone Global Markets, LLC is an affiliate of Capstone Holdings Group, LLC. Capstone Global Markets is a boutique broker dealer specializing in volatility trading strategies. The firm trades across equities, commodities, currencies, credit and fixed income markets. Capstone Global Markets provides institutional clients with access to markets in the U.S. and has a U.K. affiliate that provides access to markets in Europe. The firm's platform is based on cutting-edge technology, dynamic volatility analysis and trading strategies, and an investment in distinguished human capital.

For more information, please visit www.capstoneglobalmarkets.com.


'/>"/>
SOURCE Capstone Global Markets, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Digirad Corporation to Present at CapStone Small-Cap Investor Conference
2. LCA-Vision to Present at CapStone Investments 3rd Annual Small-Cap Investor Conference
3. NewCardio to Present at CapStones Third Annual Small-Cap Investor Conference July 30
4. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
5. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
6. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
7. Briefing on a new Web resource to address global drinking water crisis
8. MDS Pharma Services Wins Award for Management of Global Malaria Trial
9. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
10. Resonant Medical Appoints New Vice President of Global Sales
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is consistently becoming ... require expert user knowledge. In a live webinar on April 11th and October ... highly accurate, determination of sodium. , It has long been known that too ...
(Date:3/27/2017)... CA (PRWEB) , ... March 27, 2017 , ... ... has entered a settlement agreement to resolve the pending litigation between itself and ... for the District of Utah). , “I am thrilled to announce that we ...
(Date:3/27/2017)... RICHEY, Fla. (PRWEB) , ... March 27, 2017 ... ... drug overdose deaths soared 167%,(1) with opioids alone responsible for over 33,000 of ... Kevin McCarty has sponsored Assembly Bill (AB) 1512, which proposes a tax on ...
(Date:3/27/2017)... ... , ... Harris Communications, Inc., a leading provider of assistive technology for ... Deaf Seniors of America Conference, April 4-7 at the Hotel Westin Galleria in Houston. ... staff from Harris Communications and to try out the newest assistive devices available to ...
(Date:3/25/2017)... ... March 25, 2017 , ... Getting earned media coverage meaningful for Garden Media ... All through the year, Garden Media aims to provide material helpful to clients’ goals ... pitching client’s key messages to gain coveted media placements, Garden Media wows ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Therapix Biosciences Ltd. (NASDAQ: ... the development of cannabinoid-based drugs, today announced the ... the United States of 2,000,000 American ... shares of the Company, at a price of ... the underwriters a 45-day over-allotment option to purchase ...
(Date:3/27/2017)... March 27, 2017  A recent study at Shriners ... freestanding hospitals in the country dedicated to the treatment ... surgery, concluded that the Surfacide Helios ® UV-C ... in reducing bacterial pathogens not killed by the EVS ... at the American Burn Association,s 49th Annual Meeting in ...
(Date:3/27/2017)... March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an ... passed early toxicology and efficacy studies. The company is ... a specific protein, MAGE A, in an effort to ... After 4 weeks of treatment in ... very little toxicity in a full toxicology report of ...
Breaking Medicine Technology: